A detailed history of Assetmark, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Assetmark, Inc holds 227,229 shares of AZN stock, worth $15.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
227,229
Previous 214,524 5.92%
Holding current value
$15.1 Million
Previous $16.7 Million 5.83%
% of portfolio
0.05%
Previous 0.05%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$76.67 - $87.62 $974,092 - $1.11 Million
12,705 Added 5.92%
227,229 $17.7 Million
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $1.28 Million - $1.55 Million
19,193 Added 9.83%
214,524 $16.7 Million
Q1 2024

May 06, 2024

BUY
$61.03 - $69.57 $2.47 Million - $2.81 Million
40,425 Added 26.1%
195,331 $13.2 Million
Q4 2023

Feb 09, 2024

BUY
$61.89 - $69.28 $968,083 - $1.08 Million
15,642 Added 11.23%
154,906 $10.4 Million
Q3 2023

Oct 27, 2023

BUY
$64.85 - $71.7 $632,222 - $699,003
9,749 Added 7.53%
139,264 $9.43 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $346,683 - $375,941
4,959 Added 3.98%
129,515 $9.27 Million
Q1 2023

May 05, 2023

BUY
$63.15 - $71.6 $571,444 - $647,908
9,049 Added 7.83%
124,556 $8.65 Million
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $1.11 Million - $1.44 Million
20,479 Added 21.55%
115,507 $7.83 Million
Q3 2022

Nov 01, 2022

BUY
$53.02 - $135.75 $1.12 Million - $2.86 Million
21,038 Added 28.43%
95,028 $5.21 Million
Q2 2022

Aug 03, 2022

BUY
$59.26 - $71.14 $1.76 Million - $2.12 Million
29,736 Added 67.19%
73,990 $4.89 Million
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $1.31 Million - $1.58 Million
23,483 Added 113.06%
44,254 $2.94 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $428,810 - $506,682
7,938 Added 61.86%
20,771 $1.21 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $464,703 - $508,447
8,364 Added 187.16%
12,833 $771,000
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $37,622 - $46,759
777 Added 21.05%
4,469 $268,000
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $9,856 - $11,377
-209 Reduced 5.36%
3,692 $184,000
Q4 2020

Feb 10, 2021

SELL
$48.52 - $58.02 $3,833 - $4,583
-79 Reduced 1.98%
3,901 $195,000
Q3 2020

Nov 13, 2020

SELL
$53.07 - $61.1 $656,528 - $755,868
-12,371 Reduced 75.66%
3,980 $218,000
Q2 2020

Aug 11, 2020

SELL
$43.1 - $55.31 $10.7 Million - $13.7 Million
-248,110 Reduced 93.82%
16,351 $865,000
Q1 2020

May 12, 2020

SELL
$37.79 - $51.33 $331,380 - $450,112
-8,769 Reduced 3.21%
264,461 $11.8 Million
Q4 2019

Feb 11, 2020

BUY
$42.46 - $50.46 $3.93 Million - $4.67 Million
92,641 Added 51.3%
273,230 $13.6 Million
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $79,798 - $90,439
1,989 Added 1.11%
180,589 $8.05 Million
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $6.5 Million - $7.26 Million
174,229 Added 3986.02%
178,600 $7.37 Million
Q1 2019

May 14, 2019

SELL
$35.49 - $43.02 $15,757 - $19,100
-444 Reduced 9.22%
4,371 $177,000
Q4 2018

Feb 13, 2019

SELL
$36.86 - $41.49 $49,023 - $55,181
-1,330 Reduced 21.64%
4,815 $183,000
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $10,428 - $11,916
-300 Reduced 4.65%
6,145 $243,000
Q2 2018

Aug 01, 2018

SELL
$34.55 - $37.05 $2,936 - $3,149
-85 Reduced 1.3%
6,445 $226,000
Q1 2018

May 16, 2018

SELL
$32.97 - $36.63 $16,682 - $18,534
-506 Reduced 7.19%
6,530 $228,000
Q4 2017

Feb 13, 2018

SELL
$32.09 - $34.78 $3.12 Million - $3.38 Million
-97,191 Reduced 93.25%
7,036 $244,000
Q3 2017

Nov 08, 2017

SELL
$28.96 - $34.0 $3.03 Million - $3.55 Million
-104,487 Reduced 50.06%
104,227 $3.53 Million
Q2 2017

Aug 15, 2017

BUY
N/A
17,306 Added 9.04%
208,714 $7.12 Million
Q1 2017

Sep 15, 2017

BUY
N/A
82,797 Added 76.23%
191,408 $5.96 Million
Q4 2016

Sep 15, 2017

BUY
N/A
10,296 Added 10.47%
108,611 $2.97 Million
Q3 2016

Sep 15, 2017

SELL
N/A
-10,659 Reduced 9.78%
98,315 $3.23 Million
Q2 2016

Sep 15, 2017

BUY
N/A
7,894 Added 7.81%
108,974 $3.29 Million
Q1 2016

Sep 15, 2017

BUY
N/A
16,061 Added 18.89%
101,080 $2.85 Million
Q4 2015

Sep 15, 2017

BUY
N/A
85,019
85,019 $2.89 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.